{"id":"https://openalex.org/W1997980357","doi":"https://doi.org/10.1151/spp021113","title":"The Neurobiology of Opioid Dependence: Implications for Treatment","display_name":"The Neurobiology of Opioid Dependence: Implications for Treatment","publication_year":2002,"publication_date":"2002-07-01","ids":{"openalex":"https://openalex.org/W1997980357","doi":"https://doi.org/10.1151/spp021113","mag":"1997980357","pmid":"https://pubmed.ncbi.nlm.nih.gov/18567959","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2851054"},"language":"en","primary_location":{"id":"doi:10.1151/spp021113","doi":"https://doi.org/10.1151/spp021113","is_oa":false,"landing_page_url":"https://doi.org/10.1151/spp021113","pdf_url":null,"source":{"id":"https://openalex.org/S4210195889","display_name":"Science & Practice Perspectives","issn_l":"1930-4307","issn":["1930-4307","1930-4315"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Science & Practice Perspectives","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2851054","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110079326","display_name":"Thomas R. Kosten","orcid":"https://orcid.org/0000-0003-1505-555X","observed_orcids":["https://orcid.org/0000-0003-1505-555X"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Thomas Kosten","raw_affiliation_strings":["Yale University School of Medicine, New Haven, Connecticut, USA. thomas.kosten@yale.edu","Yale University School of Medicine, New Haven, Connecticut, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yale University School of Medicine, New Haven, Connecticut, USA. thomas.kosten@yale.edu","institution_ids":["https://openalex.org/I32971472"]},{"raw_affiliation_string":"Yale University School of Medicine, New Haven, Connecticut, USA","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046628089","display_name":"Tony Peter George","orcid":"https://orcid.org/0000-0003-1645-9767","observed_orcids":["https://orcid.org/0000-0003-1645-9767"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]},{"id":"https://openalex.org/I4210155461","display_name":"Connecticut Mental Health Center","ror":"https://ror.org/0569bbe51","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210155461"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tony George","raw_affiliation_strings":["Connecticut Mental Health Center New Haven, Connecticut","Yale University School of Medicine New Haven, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Connecticut Mental Health Center New Haven, Connecticut","institution_ids":["https://openalex.org/I4210155461"]},{"raw_affiliation_string":"Yale University School of Medicine New Haven, Connecticut","institution_ids":["https://openalex.org/I32971472"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5110079326"],"corresponding_institution_ids":["https://openalex.org/I32971472"],"apc_list":null,"apc_paid":null,"fwci":2.0308,"has_fulltext":false,"cited_by_count":532,"citation_normalized_percentile":{"value":0.87129016,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"1","issue":"1","first_page":"13","last_page":"20"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.004999999888241291,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.003700000001117587,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.9990000128746033},{"id":"https://openalex.org/keywords/opioid-tolerance","display_name":"opioid tolerance","score":0.8840000033378601},{"id":"https://openalex.org/keywords/neuroscience-of-addiction","display_name":"neurobiology of addiction","score":0.8529999852180481},{"id":"https://openalex.org/keywords/methadone-maintenance-treatment","display_name":"methadone maintenance treatment","score":0.7839999794960022},{"id":"https://openalex.org/keywords/laam","display_name":"LAAM","score":0.8029999732971191},{"id":"https://openalex.org/keywords/buprenorphine","display_name":"buprenorphine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/naltrexone","display_name":"naltrexone","score":1.0},{"id":"https://openalex.org/keywords/opioid-antagonists","display_name":"opioid antagonists","score":0.7009999752044678},{"id":"https://openalex.org/keywords/psychosocial-interventions","display_name":"psychosocial interventions","score":0.859000027179718},{"id":"https://openalex.org/keywords/addiction-treatment","display_name":"addiction treatment","score":0.45100000500679016}],"concepts":[{"id":"https://openalex.org/C2777972943","wikidata":"https://www.wikidata.org/wiki/Q409587","display_name":"Naltrexone","level":4,"score":0.8147277235984802},{"id":"https://openalex.org/C2778949969","wikidata":"https://www.wikidata.org/wiki/Q407721","display_name":"Buprenorphine","level":4,"score":0.792168915271759},{"id":"https://openalex.org/C2778767360","wikidata":"https://www.wikidata.org/wiki/Q179996","display_name":"Methadone","level":2,"score":0.7048419117927551},{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.6813883781433105},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.6621261835098267},{"id":"https://openalex.org/C150966472","wikidata":"https://www.wikidata.org/wiki/Q3410145","display_name":"Psychosocial","level":2,"score":0.5912999510765076},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5329955816268921},{"id":"https://openalex.org/C2993816172","wikidata":"https://www.wikidata.org/wiki/Q1639178","display_name":"Opioid addiction","level":4,"score":0.5292348861694336},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5036370158195496},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.47180262207984924},{"id":"https://openalex.org/C40010229","wikidata":"https://www.wikidata.org/wiki/Q3184856","display_name":"Substance abuse","level":2,"score":0.46732297539711},{"id":"https://openalex.org/C2909816603","wikidata":"https://www.wikidata.org/wiki/Q1639178","display_name":"Opioid-Related Disorders","level":5,"score":0.4313158690929413},{"id":"https://openalex.org/C542102704","wikidata":"https://www.wikidata.org/wiki/Q183257","display_name":"Psychotherapist","level":1,"score":0.34868672490119934},{"id":"https://openalex.org/C2777170798","wikidata":"https://www.wikidata.org/wiki/Q65087481","display_name":"Opioid epidemic","level":4,"score":0.19696176052093506},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.07929366827011108},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000701","descriptor_name":"Analgesics, Opioid","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000701","descriptor_name":"Analgesics, Opioid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008959","descriptor_name":"Models, Neurological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009292","descriptor_name":"Narcotic Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009292","descriptor_name":"Narcotic Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D009293","descriptor_name":"Opioid-Related Disorders","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D009293","descriptor_name":"Opioid-Related Disorders","qualifier_ui":"Q000534","qualifier_name":"rehabilitation","is_major_topic":false},{"descriptor_ui":"D011957","descriptor_name":"Receptors, Opioid","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016739","descriptor_name":"Behavior, Addictive","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1151/spp021113","doi":"https://doi.org/10.1151/spp021113","is_oa":false,"landing_page_url":"https://doi.org/10.1151/spp021113","pdf_url":null,"source":{"id":"https://openalex.org/S4210195889","display_name":"Science & Practice Perspectives","issn_l":"1930-4307","issn":["1930-4307","1930-4315"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Science & Practice Perspectives","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2851054","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2851054","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Sci Pract Perspect","raw_type":"Text"},{"id":"pmid:18567959","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18567959","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Science & practice perspectives","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.216.9134","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.216.9134","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.nida.nih.gov/PDF/Perspectives/vol1no1/03Perspectives-Neurobio.pdf","raw_type":"text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.355.5360","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.355.5360","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/1f/e0/Sci_Pract_Perspect_2002_Jul_1(1)_13-20.tar.gz","raw_type":"text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:2851054","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2851054","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Sci Pract Perspect","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8999999761581421}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2524567164","display_name":"Comorbidity in  Cocaine and Opioid Pharmacotherapy","funder_award_id":"K05DA000454","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G3138220751","display_name":"COCAINE PHARMACOTHERAPIES FOR COMORBID POPULATIONS","funder_award_id":"P50DA012762","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G5334802236","display_name":"Optimizing Treatment for Schizophrenic Smokers","funder_award_id":"R01DA013672","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G7687816233","display_name":"Nicotinic Receptors and Cog Function in Schizophrenia","funder_award_id":"R01DA014039","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G9000861001","display_name":"Clinician Scientist Training Program (CSTP)","funder_award_id":"K12DA000167","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"}],"funders":[{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W1577046191","https://openalex.org/W1958222516","https://openalex.org/W1986331833","https://openalex.org/W1987122239","https://openalex.org/W1989416066","https://openalex.org/W2000146111","https://openalex.org/W2002091306","https://openalex.org/W2025984191","https://openalex.org/W2029891253","https://openalex.org/W2034359651","https://openalex.org/W2060542445","https://openalex.org/W2065816932","https://openalex.org/W2069472087","https://openalex.org/W2069642322","https://openalex.org/W2090023593","https://openalex.org/W2099319294","https://openalex.org/W2105109101","https://openalex.org/W2121153184","https://openalex.org/W2145092433","https://openalex.org/W2162446389","https://openalex.org/W2580095671","https://openalex.org/W4256689613","https://openalex.org/W4290454038","https://openalex.org/W4300842755"],"related_works":["https://openalex.org/W7097113920","https://openalex.org/W2758730521","https://openalex.org/W2900750855","https://openalex.org/W2912867910","https://openalex.org/W954187130","https://openalex.org/W9978589","https://openalex.org/W2484392652","https://openalex.org/W4313172563","https://openalex.org/W2745127216","https://openalex.org/W2374897136"],"abstract_inverted_index":{"Opioid":[0],"tolerance,":[1],"dependence,":[2],"and":[3,41,49],"addiction":[4],"are":[5],"all":[6],"manifestations":[7],"of":[8,32,63],"brain":[9,47],"changes":[10],"resulting":[11],"from":[12],"chronic":[13],"opioid":[14,17],"abuse.":[15],"The":[16],"abuser's":[18],"struggle":[19,27],"for":[20],"recovery":[21],"is":[22],"in":[23,69],"great":[24],"part":[25],"a":[26],"to":[28],"overcome":[29],"the":[30,45,61],"effects":[31],"these":[33],"changes.":[34],"Medications":[35],"such":[36],"as":[37,51],"methadone,":[38],"LAAM,":[39],"buprenorphine,":[40],"naltrexone":[42],"act":[43],"on":[44],"same":[46],"structures":[48],"processes":[50],"addictive":[52],"opioids,":[53],"but":[54],"with":[55,71],"protective":[56],"or":[57],"normalizing":[58],"effects.":[59],"Despite":[60],"effectiveness":[62],"medications,":[64],"they":[65],"must":[66],"be":[67],"used":[68],"conjunction":[70],"appropriate":[72],"psychosocial":[73],"treatments.":[74]},"counts_by_year":[{"year":2026,"cited_by_count":39},{"year":2025,"cited_by_count":52},{"year":2024,"cited_by_count":43},{"year":2023,"cited_by_count":56},{"year":2022,"cited_by_count":57},{"year":2021,"cited_by_count":59},{"year":2020,"cited_by_count":51},{"year":2019,"cited_by_count":32},{"year":2018,"cited_by_count":33},{"year":2017,"cited_by_count":27},{"year":2016,"cited_by_count":22},{"year":2015,"cited_by_count":18},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}